Methods
Serum NCP was quantified using a commercial NCP-specific ELISA in
hospitalized COVID-19 patients (n=63) during their hospital stay.
Results were correlated to COVID-19 disease severity, inflammation
parameters, antibody response and results of SARS-CoV-2 PCR from
nasopharyngeal swabs.